In PNAS, Claiborne et al.
(1) use a measure of HIV-1 fitness to explore its role in events early after infection that set the course for long-term disease progression. Individuals with acute HIV-1 infection have very high viral loads, often reaching tens of million virus particles per milliliter. A battle then ensues between the host and the virus, with the virus being brought under control to a relatively steady-state level, referred to as the set-point viral load (SPVL). The rate of disease progression (measured as the rate of CD4
+ T-cell loss, which ultimately leads to immunodeficiency) is highly variable between infected individuals, and the host and viral determinants of these variable rates are of great interest. The level of the early SPVL is a significant but incomplete predictor of disease progression (2, 3) . The most important host genetic determinant of disease progression is the HLA system, implicating both innate and cellular immune responses as being important in controlling the virus (4, 5) . However, HLA only accounts for about 20% of the variation in disease progression, leaving other host factors, such as persistent immune activation (6, 7) , and viral factors as potential contributors to the rate of disease progression.
For more than 20 y, SPVL has been used as a key parameter of risk of disease progression. In the current study, Claiborne et al.
start to untangle viral replication capacity (vRC) and SPVL, which are themselves partially linked (8) , to reveal the contributions each makes separately to different aspects of the host response. The potential for revealing a role for vRC can be seen in the incomplete link between SPVL and the rate of CD4 + T-cell decline in the study cohort (1): when SPVL was very low (<10 3 copies of viral RNA per mL of plasma), CD4
+ T-cell loss was very slow; when SPVL was very high (>10 5 copies per mL), cell loss was rapid; however, binning outcomes for those with SPVL between 10 3 and 10 4 and comparing those with SPVL between 10 4 and 10 5 showed no difference in the group rates of cell loss between these two groups, even though there was wide variation in the rate of cell loss between individuals within each group (Fig. 1) . Thus, especially within this middle range of SPVL, there is an opportunity to search for additional determinants that can increase or reduce the rate of CD4 + T-cell loss. After transmission, there is an initial period of limited host response where the vRC of the transmitted virus could impact the quality of the initial interaction between the virus and the host. We now know that 80-90% of heterosexual transmission events result in a new infection founded by a single virus (9, 10) . This means the initial virus-host battle is carried out with a relatively homogeneous viral population, involving viruses carrying preexisting mutations carried over from the donor viral population. On a population basis, there is a bias against the transmission of variants with reduced in vivo fitness (11) . However, low vRC variants can be transmitted, raising the question of their contribution to different aspects of viral pathogenesis and disease progression.
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infection from a cohort of subjects (n = 127) where transmission had occurred between discordant couples (1). One gag gene from each newly infected subject was used to replace the gag gene of a cloned viral genome, and the ability of this chimeric genome to replicate as a virus in a cell line was assessed. When the chimeric virus replicated more slowly, this was taken as a sign of reduced vRC associated with the Gag protein.
Claiborne et al. first showed that, overall, there is a clear signal of reduced rate of CD4 + T-cell loss in subjects with viruses whose Gag proteins conferred reduced vRC, especially those with the lowest third of fitness values. In a multivariable analysis, the authors showed that the magnitude of the protective effect (i.e., reduced rate of CD4 + T-cell loss) in the group with the lowest fitness values was comparable in magnitude to the protective effect of the "protective" HLA alleles B*57 and B*58:01 and that these variables were additive in their protective effects.
Viral properties have been shown to play a role in pathogenesis in several other settings. Individuals infected with subtype C or D HIV-1 have more rapid disease progression than those infected with subtype A (12-14) . There is a trend for transmission pairs to have more similar SPVL than if there was no transmission link (15, 16) . The viral capsid protein, present within the Gag polyprotein precursor, is the site of important T-cell epitope targets, and immune responses to Gag can be more important than responses to other viral proteins in terms of controlling viral replication (17, 18) . Furthermore, individuals infected with viruses containing immune escape mutations within these epitopes that affect vRC tend to have an improved disease outcome (8, 19, 20) .
Claiborne et al. also explore the possibility that vRC could impact, at this very early time point after infection, other features of the host response. They found that individuals infected with viruses with higher vRC had 1.5-to 2-fold higher levels of inflammatory cytokines in the plasma around the time of seroconversion and that a significant subset of these cytokines was more closely linked to vRC rather than SPVL. Similarly, the presence of virus with a higher vRC correlated with the presence of a CD8 + T-cell population with higher levels of PD-1 and lower levels of CD57, indicative of T-cell exhaustion, and these markers correlated with faster
With HIV-1 vRC, we can start to account for some of the variance in SPVL as a determinant of the rate of CD4 + T-cell loss.
CD4
+ T-cell decline. Also, the CD8 + T-cell population showed higher levels of the activation markers CD38 and HLA-DR, which also correlated with faster CD4
+ T-cell decline. Importantly, in a multivariable analysis, these effects were shown to have a vRC component that was distinct from SPVL. Similar effects were linked to activation markers on CD4 + T cells. Finally, Claiborne et al. examined the levels of viral DNA in different CD4
+ T-cell subsets. They found that viral DNA levels were higher in both naive and central memory CD4
+ T-cell subsets in subjects infected with high vRC virus. This observation led them to suggest that people with high vRC virus may have a larger latent reservoir, which is thought to reside in the central memory CD4
+ T-cell subset, although in the present study, most of the viral DNA they detected was from actively replicating virus in these untreated subjects.
In conclusion, although SPVL has been an essential tool in developing our understanding of HIV-1 pathogenesis and disease progression, it does not explain everything. With HIV-1 vRC, we can start to account for some of the variance in SPVL as a determinant of the rate of CD4 + T-cell loss. It is possible that the rate or ease of viral replication in different subsets of CD4 + T cells varies as a function of vRC, but in subsets that make only a small contribution to the overall SPVL. Unlinking the effects of SPVL and vRC provides us with a new tool for probing the complex nature of the effects of HIV-1 on the quality of the human immune response to the virus.
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